Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome

Human Reproduction

Volumn 15, Issue 6, 2000, Pages 1266-1274

  Morin Papunen, Laure C ^a   Vauhkonen, Ilkka ^a   Koivunen, Riitta M ^a   Ruokonen, Aimo ^a   Tapanainen, Juha S ^a  

^a NONE

Author keywords

Early phase secretion of insulin; Insulin sensitivity; Polycystic ovarian syndrome

Indexed keywords

INSULIN;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GLUCOSE METABOLISM; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE;

FALLOPIA;

EID: 0034119173     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.6.1266     Document Type: Article

References (53)

1. Acien, P., Quereda, F., Matallin, P. et al. (1999) Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders. Fertil. Steril., 71, 32-40.
2. Anonymous (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus [see comments]. Diabetes Care, 20, 1183-1197.
3. Baker, B., Mandarino, L., Brick, B. et al. (1984) Influence of changes in insulin receptor binding during insulin infusions on the shape of the insulin dose-response curve for glucose disposal in man. J Clin. Endocrinol. Metab., 58, 392-396.
4. Björntorp, P. (1997) Body fat distribution, insulin resistance, and metabolic diseases. Nutrition, 13, 795-803.
5. Bringer, J., Lefebvre, P., Boulet, F. et al. (1993) Body composition and regional fat distribution in polycystic ovarian syndrome. Relationship to hormonal and metabolic profiles. Ann. NY Acad. Sci., 687, 115-123.
6. Campbell, P.J. and Gerich, J.E. (1990) Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity. J. Clin. Endocrinol. Metab., 70, 1114-1118.
7. Chang, R.J., Nakamura, R.M., Judd, H.L. et al. (1983) Insulin resistance in nonobese patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab., 57, 356-359.
8. Ciampelli, M., Fulghesu, A.M., Cucinelli, F. et al. (1997) Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome. Hum. Reprod., 12, 1897-1901.
9. Ciaraldi, T.P., El-Roeiy, A., Madar, Z. et al. (1992) Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J. Clin. Endocrinol. Metab., 75, 577-583.
10. Cook, D., Godsland, I.F., Hull, J. et al. (1997) Hormone replacement therapy with dydrogesterone and 17 b-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up. Br. J. Obstet. Gynaecol., 104, 298-304.
11. Dahlgren, E., Janson, P.O., Johansson, S. et al. (1992) Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet. Gynecol. Scand., 71, 599-604.
12. DeFronzo, R.A., Tobin, J.D. and Andres, R. (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol., 237, E214-223.
13. Dunaif, A., Graf, M., Mandeli, J. et al. (1987) Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J. Clin. Endocrinol. Metab., 65, 499-507.
14. Dunaif, A., Segal, K.R., Futterweit, W. et al. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165-1174.
15. Dunaif, A., Segal, K.R., Shelley, D.R. et al. (1992) Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes, 41, 1257-1266.
16. Dunaif, A., Xia, J., Book, C.B. et al. (1995) Excessive insulin receptor serine phosphorylation in cultured ribroblasis and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J. Clin. Invest., 96, 801-810.
17. Ehrmann, D.A., Sturis, J., Byrne, M.M. et al. (1995) Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J. Clin. Invest., 96, 520-527.
18. Ehrmann, D.A., Barnes, R.B., Rosenfield R.L. et al. (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care, 22, 141-146.
19. Faber, O.K., Hagen, C., Binder, C. et al. (1978) Kinetics of human connecting peptide in normal and diabetic subjects. J. Clin. Invest., 62, 197-203.
20. Ferrannini, E. (1988) The theoretical bases of indirect calorimetry: a review. Metab. Clin. Exp., 37, 287-301.
21. Ferrannini, E., Barrett, E.J., Bevilacqua, S. et al. (1983) Effect of fatty acids on glucose production and utilization in man. J. Clin. Invest., 72, 1737-1747.
22. Ferriman, D. and Gallwey, J.D. (1961) Clinical assessment of body hair growth in women. J Clin. Endocrinol. Metab., 21, 1440-1447.
23. Gray, A., Feldman, H.A., McKinlay, J.B. et al. (1991) Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J. Clin. Endocrinol. Metab., 73, 1016-1025.
24. Hammami, M.M. and Siiteri, P.K. (1991) Regulation of 11b-hydroxysteroid dehydrogenase activity in human skin ribroblasts: enzymatic modulation of glucocorticoid action. J. Clin. Endocrinol. Metab., 73, 326-334.
25. Holmang, A., Svedberg, J., Jennische, E. et al. (1990) Effects of testosterone on muscle insulin sensitivity and morphology in female rats. Am. J. Physiol., 259, E555-560.
26. Holte, J., Bergh, T., Berne, C. et al. (1994a) Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J. Clin. Endocrinol. Metab., 78, 1052-1058.
27. Holte, J., Bergh, T., Berne, C. et al. (1994b) Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Clin. Endocrinol., 41, 463-471.
28. Holte, J., Bergh, T., Berne, C. et al. (1995) Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 80, 2586-2593.
29. Homburg, R. (1996) Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy. Hum. Reprod., 11, 29-39.
30. Insel, J.R., Kolterman, O.G., Saekow, M. et al. (1980) Short-term regulation of insulin receptor affinity in man. Diabetes, 29, 132-139.
31. Kosaka, K., Kuzuya, T., Hagura, R. et al. (1996) Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diabet. Med., 13, S109-119.
32. Laakso, M., Uusitupa, M., Takala, J. et al. (1988) Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycaemia in obese non-insulin-dependent diabetic subjects. Metab. Clin. Exp., 37, 1092-1100.
33. Mandarino, L., Baker, B., Rizza, R. et al. (1984) Infusion of insulin impairs human adipocyte glucose metabolism in vitro without decreasing adipocyte insulin receptor binding. Diabetologia, 27, 358-363.
34. Martikainen, H., Salmela, P., Nuojua-Huttunen, S. et al. (1996) Adrenal steroidogenesis is related to insulin in hyperandrogenic women. Fertil. Steril., 66, 564-570.
35. McKenna, T.J. and Cunningham, S.K. (1995) Adrenal androgen production in polycystic ovary syndrome. Eur. J. Endocrinol., 133, 383-389.
36. Moghetti, P., Castello, R., Negri, C. et al. (1996) Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity. J. Clin. Endocrinol. Metab., 81, 881-886.
37. Morales, A.J., Laughlin, G.A., Butzow, T. et al. (1996) Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J. Clin. Endocrinol. Metab., 81, 2854-2864.
38. Nankervis, A., Proietto, J., Aitken, P. et al. (1985) Hyperinsulinaemia and insulin insensitivity: studies in subjects with insulinoma. Diabetologia, 28, 427-131.
39. Ovesen, P., Moller, J., Ingerslev, H.J. et al. (1993) Normal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 77, 1636-1640.
40. Peiris, A.N., Aiman, E.J., Drucker, W.D. et al. (1989) The relative contributions of hepatic and peripheral tissues to insulin resistance in hyperandrogenic women. J. Clin. Endocrinol. Metab., 68, 715-720.
41. Plymate, S.R., Matej, L. A., Jones, R.E. et al. (1988) Inhibition of sex hormone-binding globulin in the hepatoma (Hep G2) cell line by insulin and prolactin. J. Clin. Endocrinol. Metab., 67, 460-464.
42. Polderman, K.H., Gooren, L.J., Asscheman, H. et al. (1994) Induction of insulin resistance by androgens and estrogens. J. Clin. Endocrinol. Metab., 79, 265-271.
43. Polonsky, K., Jaspan, J., Pugh, W. et al. (1983) Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. J. Clin. Invest., 72, 1114-1123.
44. Randle, R., Hales, C., Garlandy, P. et al. (1963) The glucose fatty acid cycle and its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet, 1, 785-789.
45. Rebuffe-Scrive, M., Cullberg, G., Lundberg, P.A. et al. (1989) Anthropometric variables and metabolism in polycystic ovarian disease. Horm. Metab. Res., 21, 391-397.
46. Robert, Y., Dubrulle, F., Gaillandre, L. et al. (1995) Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized qualification. Fertil. Steril., 64, 307-312.
47. Robinson, S., Kiddy, D., Gelding, S.V. et al. (1993) The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin. Endocrinol., 39, 351-355.
48. Rodin, A., Thakkar, H., Taylor, N. et al. (1994) Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase [see comments]. N. Engl. J. Med., 330, 460-465.
49. Shuster, L.T., Go, V.L., Rizza, R.A. et al. (1988) Incretin effect due to increased secretion and decreased clearance of insulin in normal humans. Diabetes, 37, 200-203.
50. Steward, P.M., Boulton, A., Kumar, S. et al. (1999) Cortisol metabolism in human obesity: impaired cortisone-cortisol conversion in subjects with central adiposity. J. Clin. Endocrinol. Metab., 84, 1022-1027.
51. Waldhausl, W.K., Bratusch-Marrain, P., Gasic, S. et al. (1986) Inhibition by proinsulin of endogenous C-peptide release in healthy man. Am. J. Physiol., 251, E139-145.
52. Wareham, N.J., Phillips, D.I., Byrne, C.D. et al. (1995) The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion [letter; comment]. Diabet. Med., 12, 931.
53. Zhang, L.H., Rodriguez, H., Ohno, S. et al. (1995) Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc. Natl. Acad. Sci. USA, 92, 10619-10623.